Health Care

Medical Device Industry

Medical Device Industry

NERA's experience in analyzing markets for medical devices and services spans a wide range of cases and issues. NERA's economists have been retained by both law firms and suppliers of medical devices to analyze the competitive issues that often arise in the context of mergers and acquisitions as well as other antitrust, contract dispute, licensing, and patent infringement matters. NERA staff members have testified and provided written analyses of pricing and innovation for a variety of medical technologies. They have extensive experience calculating patent damages, performing intellectual property valuations, and conducting transfer-pricing studies. Examples of NERA's recent work in this area include:

  • Evaluating the competitive effects in pricing and innovation in eye care products, diagnostic testing equipment, reagents, and services in connection with a series of mergers and acquisitions;
  • Studying the competitive effects on pricing and innovation in implantable cardioverter defibrillators (ICDs) and pacemakers in connection with recent industry acquisitions and licensing issues;
  • Analyzing competitive issues with respect to heart-lung machines, oxygenators, and other bypass surgery peripherals in a recent sequence of industry acquisitions;
  • Evaluating competitive issues in dental and spinal implants for recent acquisitions;
  • Studying dynamics and competitive issues for medical reimbursement software products and services, as well as pharmaceutical information/utilization products and software, in the context of recent industry consolidation; and
  • Testifying on liability and damage issues for a manufacturer of lithotripers sued by a repair service provider seeking access to service manuals and replacement parts.

Please click here for more information about the firm's expertise in the medical devices industry.

Name Title Location Phone Email
Dr. Lawrence Wu President San Francisco +1 415 291 1007
Dr. Christine Siegwarth Meyer Senior Managing Director White Plains, NY +1 914 448 4119
Dr. Subramaniam (Subbu) Ramanarayanan Senior Managing Director New York City
Los Angeles
+1 212 345 0745
+1 213 346 3038
Dr. Elizabeth Newlon Managing Director Los Angeles +1 213 346 3019
Dr. Paul Wong Managing Director San Francisco +1 415 291 1030
Dr. Emily Walden Director Washington, DC +1 202 466 9220
Brigid Jung Senior Consultant New York City +1 212 345 7039
Dr. Thomas McCarthy Affiliated Consultant Los Angeles +1 213 346 3000
Title Type Author
The Algorithmic Accountability Act: Potential Coverage Gaps in the Healthcare Sector Published Article Dr. Andrew Stivers and Dr. Gabriella Monahova
The Role of Rebates in the Pharmaceutical Industry Published Article Dr. Chris Stomberg
Non-Compete Agreements: Might They Be Procompetitive in Health Care? Published Article Dr. Paul Wong and Dr. Emily Walden
Drug Rebates: A Peek Behind the Curtain at Drug Prices Published Article Dr. Christopher Stomberg
Taking Stock of the Efficiencies Defense: Lessons from Recent Health Care Merger Revi... Published Article Dr. Subramaniam Ramanarayanan
Paper Trail: Review of a Recent Working Paper on the Effect of Copay Coupons on Drug ... Published Article Bryan Ray and Dr. Subbu Ramanarayanan
The Economic Impact Of New MMSEA Regulations Published Article Dr. Denise Neumann Martin, Dr. Stephanie Plancich, and Mary Elizabeth Stern